RECENT ADVANCES IN IMMUNOTHERAPY AND TARGETED THERAPIES FOR HEPATOCELLULAR CARCINOMA (HCC): MOLECULAR MECHANISMS, CLINICAL PROGRESS, AND FUTURE DIRECTIONS. rjnmsr [Internet]. 2025 Dec. 11 [cited 2026 Sep. 21];3(8):48-83. Available from: https://nmsreview.org/index.php/rjnmsr/article/view/523